AstraZeneca has increased its investment in U.S. operations more than 14-fold, committing $50 billion to a range of ...

As President Donald Trump’s tariff policies loom, global pharmaceutical giant AstraZeneca will invest $50 billion to boost ...

AstraZeneca said it plans to invest $50 billion in the U.S. by 2030, including a proposal for a new drug substance manufacturing center focused on weight-loss drugs. The U.K. biopharmaceutical giant ...

Commerce Secretary Howard Lutnick said Trump's new tariff policies are focused on ending the U.S.'s reliance on foreign supply of key pharmaceutical products. "We are proud that AstraZeneca has made ...

AstraZeneca Plc. announced on Monday that it plans to invest $50 billion in the U.S. by 2030, with a focus on expanding drug ...

Dr. George Tidmarsh, a Stanford pediatrics adjunct professor and former pharmaceutical executive, is FDA Commissioner Marty Makary’s pick to be the nation’s top drug regulator.

The investment is highlighted by a state-of-the-art API facility in Virginia and expansions across multiple states.